Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study.

Kamil ChwojnickiDorota Iwaszkiewicz-GrześAnna JankowskaMaciej ZielińskiPaweł ŁowiecMateusz GliwińskiMałgorzata GrzywińskaKamil KowalczykAleksandra KonarzewskaPaulina GlasnerJustyna SakowskaJulia KulczyckaAnna Jaźwińska-CuryłłoMarlena KubachBartosz KaraszewskiWalenty NykaEdyta SzurowskaPiotr Trzonkowski

Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)

EudraCT: 2014-004320-22; registered 18 November 2014.

Keyphrases

regulatory t cells
multiple sclerosis
open label
dendritic cells
white matter
double blind
placebo controlled
clinical trial
randomized controlled trial
rheumatoid arthritis
immune response